Ovintiv INC

Market Movers (8-K)

See all →
NYSE
Ovintiv Inc. announced robust second quarter 2026 financial and operating results, highlighted by strong cash flow generation, increased share buybacks, and an upward revision to full-year production guidance.
NYSE
Ovintiv Inc. announced robust first quarter 2026 financial and operating results, highlighted by significant cash flow generation, strategic asset acquisitions and divestitures, and a strengthened balance sheet.
NYSE
Ovintiv Inc. shareholders successfully re-elected all director nominees and ratified the appointment of independent auditors at the 2026 Annual Meeting.
NYSE
Ovintiv Inc. announced the closing of its Anadarko asset sale for $2.9 billion and the redemption of its $700 million in 5.650% Notes due 2028.
NYSE
Ovintiv Inc. has filed an amended Form 8-K to incorporate the audited financial statements of NuVista Energy Ltd. and related pro forma financial information following its acquisition.
NYSE
Ovintiv Inc. announced strong Q4 and full-year 2025 results, completing its strategic transformation and unveiling an enhanced shareholder return framework.
Better than expected

Quarterly Earnings (10-Q)

See all →
NYSE
Ovintiv Inc. announced its financial and operational results for the second quarter and first six months of 2026, highlighting significant asset divestitures and acquisitions, alongside strong operational performance.
NYSE
Ovintiv Inc. reported a net loss of $630 million for Q1 2026, impacted by significant impairments, while also completing a major acquisition and preparing for a large divestiture.
Worse than expected
NYSE
Ovintiv Inc. reports Q3 2025 net earnings of $148 million, driven by strategic acquisitions and operational efficiencies, despite lower oil prices and a significant impairment in Canadian operations.
Capital raise
Worse than expected
NYSE
Ovintiv Inc. reported a significant drop in net earnings for the first half of 2025 due to a non-cash impairment, while demonstrating strong operational performance, exceeding production guidance, and actively managing its debt and capital returns.
Worse than expected
NYSE
Ovintiv Inc. reports a net loss for Q1 2025, influenced by a non-cash ceiling test impairment and strategic asset acquisitions and divestitures.
Worse than expected
NYSE
Ovintiv Inc. announced its third-quarter 2024 results, reporting net earnings of $507 million and exceeding production guidance, while also updating its full-year outlook.
Better than expected

Annual Reports (10-K)

NYSE
Ovintiv Inc. reported net earnings of $1,242 million for fiscal year 2025, driven by strategic acquisitions and operational efficiencies, while navigating lower oil prices and divesting non-core assets.
Capital raise
Delay expected
NYSE
Ovintiv Inc.'s 10-K filing summarizes the company's financial performance for 2024, highlights strategic moves including an acquisition and divestiture, and outlines future outlook.
NYSE
Ovintiv amends change in control agreements for key executives, reports full year 2023 results including a net income of $2.085 billion, and provides a 2024 outlook with a focus on capital efficiency and shareholder returns.

Insider Trading (Form 4)

See all →
NYSE
Rachel Maureen Moore, EVP, Corporate Services of Ovintiv Inc., sold 7,753 shares of common stock on August 12, 2026 for $63.32 per share.
NYSE
Brendan Michael Mccracken, President & CEO and a Director of Ovintiv Inc., reported multiple transactions in common stock on August 11, 2026.
NYSE
Brendan Michael Mccracken, President & CEO and a Director of Ovintiv Inc., reported multiple transactions in common stock on August 7, 2026.
NYSE
Brian Gordon Shaw, a Director of Ovintiv Inc., received 404 shares of common stock on July 29, 2026.
NYSE
Sippy Chhina, a Director of Ovintiv Inc., received 404 shares of common stock on July 29, 2026.
NYSE
Ralph Izzo, a Director of Ovintiv Inc., received 402 shares of common stock on July 29, 2026.

Proxy Statements (Def-14A)

NYSE
Ovintiv Inc. delivered strong financial results and advanced its strategic portfolio transformation in 2025, highlighted by key acquisitions and divestitures, operational outperformance, and significant debt reduction.
Better than expected
NYSE
Ovintiv Inc. announces its 2025 Annual Meeting of Shareholders, providing details on voting procedures and key proposals.
NYSE
Ovintiv delivered strong financial results in 2024, generating $1.7 billion in free cash flow and returning over $900 million to shareholders, while also high-grading its portfolio through strategic acquisitions and divestitures.
Better than expected
NYSE
Ovintiv's 2024 proxy statement highlights the company's strong 2023 financial results, shareholder returns, and commitment to sustainability, while outlining key corporate governance practices and executive compensation details.
Better than expected

Schedule 13G - Passive Investments

See all →
NYSE
Capital Research Global Investors has disclosed a beneficial ownership of 19,459,649 shares, representing 6.9% of Ovintiv Inc.'s common stock as of June 30, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported beneficial ownership of 9.2% of Ovintiv Inc.'s common stock as of June 30, 2026.
NYSE
Vanguard Capital Management has reported a beneficial ownership of 5.19% in Ovintiv Inc. common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 15,185,994 shares, representing 5.35% of Ovintiv Inc.'s common stock, as of March 31, 2026.
NYSE
The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Ovintiv Inc. following an internal realignment on January 12, 2026.
NYSE
FMR LLC and Abigail P. Johnson have reported an 8.1% beneficial ownership stake in Ovintiv Inc. common stock as of September 30, 2025.